Kodiak Sciences Inc

K27

Company Profile

  • Business description

    Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

  • Contact

    1200 Page Mill Road
    Palo AltoCA94304
    USA

    T: +1 650 281-0850

    E: [email protected]

    https://www.kodiak.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    109

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,175.1049.900.61%
CAC 407,536.2633.480.45%
DAX 4022,242.45177.940.81%
Dow JONES (US)40,113.5020.100.05%
FTSE 1008,415.257.810.09%
HKSE21,980.7470.980.32%
NASDAQ17,382.94216.901.26%
Nikkei 22535,705.74666.591.90%
NZX 50 Index12,017.8461.370.51%
S&P 5005,525.2140.440.74%
S&P/ASX 2007,968.2047.700.60%
SSE Composite Index3,295.062.23-0.07%

Market Movers